TimesSquare Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,165	Closed	-$638K	–	242
2021 Q2	$638K	Buy	3,165 +200	+7%	+$41.8K	0.01%	213
2021 Q1	$637K	Buy	2,965 +455	+18%	+$99.9K	0.01%	212
2020 Q4	$593K	Sell	2,510 -425	-14%	-$97.5K	﹤0.01%	219
2020 Q3	$799K	Sell	2,935 -13,550	-82%	-$3.74M	0.01%	216
2020 Q2	$4.79M	Sell	16,485 -443,855	-96%	-$120M	0.05%	205
2020 Q1	$110M	Sell	460,340 -21,530	-4%	-$4.94M	1.31%	6
2019 Q4	$106M	Sell	481,870 -133,350	-22%	-$27M	0.94%	17
2019 Q3	$104M	Buy	615,220 +105,030	+21%	+$18.6M	0.92%	19
2019 Q2	$93.6M	Sell	510,190 -10,585	-2%	-$1.85M	0.72%	37
2019 Q1	$95.8M	Buy	520,775 +49,855	+11%	+$9.21M	0.74%	39
2018 Q4	$78M	Sell	470,920 -84,160	-15%	-$14.6M	0.67%	44
2018 Q3	$107M	Sell	555,080 -128,730	-19%	-$22.9M	0.71%	40
2018 Q2	$116M	Buy	683,810 +163,480	+31%	+$25.3M	0.78%	29
2018 Q1	$84.8M	Buy	520,330 +3,315	+0.6%	+$541K	0.58%	56
2017 Q4	$77.5M	Buy	517,015 +51,325	+11%	+$7.6M	0.51%	70
2017 Q3	$70.8M	Sell	465,690 -24,655	-5%	-$3.71M	0.47%	77
2017 Q2	$63.2M	Sell	490,345 -81,755	-14%	-$9.84M	0.41%	98
2017 Q1	$62.6M	Sell	572,100 -156,600	-21%	-$13.8M	0.4%	103
2016 Q4	$53.7M	Sell	728,700 -6,210	-0.8%	-$505K	0.36%	109
2016 Q3	$64.1M	Buy	734,910 +25,000	+4%	+$2.36M	0.41%	96
2016 Q2	$61.1M	Buy	+709,910	New	+$61.3M	0.4%	99
2015 Q1	–	Sell	-900	Closed	-$107K	–	257
2014 Q4	$107K	Hold	900	–	–	﹤0.01%	245
2014 Q3	$101K	Buy	900 +600	+200%	+$57.1K	﹤0.01%	245
2014 Q2	$28K	Buy	+300	New	+$21K	﹤0.01%	239